BRR : 10289156
Click Here To View Tendering Authority. Price Bid City/State :  parel, Maharashtra
Tender Brief : Purchase Of Drugs Tender For Innovator/Original Drugs , Name Of Items : , Abemaciclib , Abemaciclib , Alectinib , Alpelisib , Alteplase , Amivantamab , Asciminib , Atezolizumab , Avelumab , Brentuximab Vedotin , Capecitabine+Cyclophosphamide , Capecitabine+Cyclophosphamide , Capmatinib , Carmustine , Cladribine , Dabrafenib , Dabrafenib , Dacomitinib , Dacomitinib , Daratumumab + Hyaluronidase-Fihj , Darolutamide , Docetaxel Nanosomal(Lipid Suspension) , Docetaxel Nanosomal(Lipid Suspension) , Docetaxel Nanosomal(Lipid Suspension) , Durvalumab , Durvalumab , Enfortumab Vedotin , Enfortumab Ve... Read More
Tender Value
3,20,00,00,000
Submission Date
22-07-2025
Participated Bidder List
32 No of Bidder(s)
Sr No. Bidder Name Bid Analytics Technical Bid Financial Bid AOC Bid Value Rank
1 cnet-technologies Bid Analytics
2 cnet-technologies Bid Analytics
3 cnet-technologies Bid Analytics
4 cnet-technologies Bid Analytics
5 cnet-technologies Bid Analytics
6 cnet-technologies Bid Analytics
7 cnet-technologies Bid Analytics
8 cnet-technologies Bid Analytics
9 cnet-technologies Bid Analytics
10 cnet-technologies Bid Analytics
11 cnet-technologies Bid Analytics
12 cnet-technologies Bid Analytics
13 cnet-technologies Bid Analytics
14 cnet-technologies Bid Analytics
15 cnet-technologies Bid Analytics
16 cnet-technologies Bid Analytics
17 cnet-technologies Bid Analytics
18 cnet-technologies Bid Analytics
19 cnet-technologies Bid Analytics
20 cnet-technologies Bid Analytics
21 cnet-technologies Bid Analytics
22 cnet-technologies Bid Analytics
23 cnet-technologies Bid Analytics
24 cnet-technologies Bid Analytics
25 cnet-technologies Bid Analytics
26 cnet-technologies Bid Analytics
27 cnet-technologies Bid Analytics
28 cnet-technologies Bid Analytics
29 cnet-technologies Bid Analytics
30 cnet-technologies Bid Analytics
31 cnet-technologies Bid Analytics
32 cnet-technologies Bid Analytics
Work Detail
purchase of drugs tender for innovator/original drugs , name of items : , abemaciclib , abemaciclib , alectinib , alpelisib , alteplase , amivantamab , asciminib , atezolizumab , avelumab , brentuximab vedotin , capecitabine+cyclophosphamide , capecitabine+cyclophosphamide , capmatinib , carmustine , cladribine , dabrafenib , dabrafenib , dacomitinib , dacomitinib , daratumumab + hyaluronidase-fihj , darolutamide , docetaxel nanosomal(lipid suspension) , docetaxel nanosomal(lipid suspension) , docetaxel nanosomal(lipid suspension) , durvalumab , durvalumab , enfortumab vedotin , enfortumab vedotin , entrectinib , entrectinib , enzalutamide , factor vii eptacog alfa(human recombinant coagulation factor vii activated r-dna origin) , factor vii eptacog alfa(human recombinant coagulation factor vii activated r-dna origin) , fosfestrol , fosnetupitant+palonosetron , gilteritinib , glofitamab , glofitamab , goserelin , goserelin , idarubicin , imatinib , imatinib , inotuzumab , ipilimumab , irinotecan liposomal , isavuconazole , isavuconazole , leuprolide acetate , lorlatinib , lorlatinib , luspatercept , luspatercept , mercaptopurine , meropenem , meropenem , mycobacterium w.(heat killed) immunomodulator , nanosomal paclitaxel lipidsuspension , nanosomal paclitaxel lipidsuspension , nimotuzumab , nintedanib , nintedanib , obinutuzumab , osimertinib , osimertinib , paclitaxel nanoparticle , palanosetron+netupitant(combipack) , panitumumab , pegaspargase , pembrolizumab , pertuzumab+trastuzumab , pertuzumab+trastuzumab , polatuzumab vedotin , ramucirumab , ramucirumab , ribociclib , ruxolitinib , ruxolitinib , ruxolitinib , ruxolitinib , sodium copper chlorophyllin , sodium copper chlorophyllin , teclistamab , teclistamab , tepotinib , thyrotropin alfa , tocilizumab , tocilizumab , tocilizumab , toripalimab , trametinib , trametinib , trastuzumab deruxtecan , tremelimumab , triptorelin , triptorelin , triptorelin , venetoclax , venetoclax , venetoclax , voriconazole , voriconazole , voriconazole
View Original Notice/Document
Result Documents
Tender Documents
Download File Name File Description
Download 33f7aa94-7acd-40f9-aa56-75fb54d1af33 financialevaluation notice
Download boqcomparativechart boq document
Download finsummary_908025 aoc document
Download File Name File Description
Download TenderDocument Tender Documents
Download Tendernotice_1 Tender Documents
Download 90c6b22b-fff1-4281-9259-bb55f664a722 Tender Documents
Download BOQ_908025 Tender Documents
Download Technicalsheet202527 Tender Documents
Disclaimer

We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender

Financial Evaluation In Progress

Financial bids are currently under review. Awarded bidder information will be published after final evaluation.

PriceBid
Similar Tenders Results
TenderDetail
Loading tenders